CVS Health Reports Appointment of David Joyner as Chair of the Board
Summary
CVS Health Corporation's Board of Directors appointed J. David Joyner, current President and Chief Executive Officer, to the additional role of Chair of the Board, effective January 1, 2026. The appointment was made on November 20, 2025, as announced via an Exhibit 99.1 press release. Following the effective date, Michael F. Mahoney will continue as the Board's Lead Independent Director. Roger N. Farah, currently Executive Chair, will continue to serve on the Board.
Why It Matters
This appointment, effective January 1, 2026, signals the Board's confidence in Mr. Joyner's leadership, recognizing his "significant operational, financial and cultural improvements" and nearly 40 years of experience, as stated in the Exhibit 99.1 press release. It consolidates leadership, aiming to drive future growth opportunities for the company.
These filing summaries are free and always will be. If this helped you spot material events, consider supporting us.
Want to see how CVS traded around this filing?
Check real-time charts and technical analysis on TradingView to see market reaction to this event.
View CVS Charts on TradingViewAffiliate link
Key Quote
“On November 20, 2025, the Board of Directors (the "Board") of CVS Health Corporation (the "Company") appointed J.”
— From Item 8.01
Filing Details
Reported Items
Additional Information
- CIK Number
- 0000064803
- Filing Date
- Thursday, November 20, 2025
- Filing Time
- 12:00 AM UTC
- Form Type
- 8-K
- Materiality Level
- medium
- Sentiment
- positive